Apple Develops China-Specific AI Model With Alibaba as Apple Intelligence Launch Nears 
Super Micro Stock Jumps 19% as AI Server Demand Drives Strong 2027 Outlook 
CBA Posts Record A$10.98B Profit Despite Cautious Outlook 
Paramount Weighs CNN Sale as $110B Warner Bros. Discovery Deal Faces Antitrust Fight 
SMIC Shares Rally as Q2 Profit Surges 262% on Strong Chip Demand 
Sanrio Shares Plunge as Q1 Profit Miss Overshadows Strong Sales 
LG, Nvidia Expand AI Partnership With Humanoid Robots, AI Factories 
Antofagasta Shares Drop 5% as Miner Cuts 2026 Copper Production Forecast 
Thyssenkrupp Raises 2026 Profit Outlook as Steel and Materials Units Strengthen 
ASX Faces Legal Action Over Failed Blockchain CHESS Project 
Google Pushes Gemini AI Overhaul as Sergey Brin Targets Model Supremacy 
Samsung, SK Hynix Shares Surge on Report of Potential Temasek Investment 
Aviva First-Half Operating Profit Jumps 24% as Direct Line Deal Boosts Growth 
China Automakers Accelerate Global Expansion as Domestic Car Sales Slump 
Cisco Forecasts Strong Fiscal 2027 Growth as AI Networking Demand Surges 
Bank of America to Buy Up to 49.9% Stake in Jio Credit for $1.92 Billion 
Australia’s Corporate Leaders Face Parliament Over KPMG Client Data Scandal 
Add as a preferred source on Google
Illumina, Inc., a San Diego, California-headquartered biotechnology firm, announced that its chief financial officer, Joydeep Goswani, is leaving. His departure was confirmed on Tuesday, April 9.
New Executives at the HQ
The company said it has appointed Ankur Dhingra as its new CFO. Goswani's successor is revealed to be an executive at Summit Therapeutics. He will be leaving the company, where he most recently served in the same chief financial role, to join Illumina.
Aside from Dhingra, Illumina is also welcoming Jakob Wedel, who has been named the new chief strategy and corporate development officer. At any rate, Reuters reported that the new CFO worked at CareDx, a medical test manufacturer, before being hired at Summit Therapeutics. He also spent almost 18 years at Agilent Technologies and has decades of experience in the life science business sector.
Relocation and Date of Leadership Appointments
Meanwhile, Illumina's newly appointed senior executives, Dhingra and Wedel, are set to be transferred to San Diego for their respective roles. The two will start working at the company on April 15. On the other hand, Goswami will remain in the company until June 30 and officially leave on July 1.
"I am proud of the talent joining our management team as we work to deliver on Illumina's mission to improve human health by unlocking the power of the genome," Illumina's chief executive officer, Jacob Thaysen, said in a press release. "Ankur brings deep financial expertise, investor and leadership experience, and industry knowledge to Illumina's CFO role, and Jakob has keen insights gained from 25 years in strategy leadership roles with global consulting firms."
The CEO added, "We are grateful to Joydeep for his many contributions to Illumina over more than four years, and for most recently leading these two key functions. Joydeep will continue with us for several weeks to support a smooth leadership transition."
Photo by: Illumina Press Release
